04.08.2010 • News • Pfizer • emerging markets • portfolio

Pfizer CFO Eyeing Emerging Market Deals

Pfizer CFO Frank DAmelio
Pfizer CFO Frank D'Amelio

Pfizer is on the lookout for further acquisitions in the area of emerging markets, established products, inflammatory diseases as well as cancer and alzheimer, German daily Handelsblatt said, citing the drug maker's chief financial officer. Pfizer CFO Frank D'Amelio told Handelsblatt that the world's largest drug maker was interested in bolt-on acquisitions. On Tuesday Pfizer posted higher-than-expected quarterly results.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature